Literature DB >> 2616734

Kidney biopsy in SLE. I. A clinical-morphologic evaluation.

D D Gladman1, M B Urowitz, E Cole, S Ritchie, C H Chang, J Churg.   

Abstract

The relationship between renal morphology and clinical disease was analysed in 148 patients with SLE attending a lupus clinic. Patients were not selected for renal disease. Renal tissue was assessed according to the World Health Organization classification of lupus nephritis, the presence of active and chronic lesions was recorded and disease activity was measured according to a standard protocol. All sections of the classification were represented in this group of patients. Active and chronic lesions were more likely to occur among patients with Class III/IV (proliferative glomerulonephritis), than in any other category. Patients with Class III/IV biopsy were more likely to have evidence of clinical renal disease than patients in Class II (mesangial). However, almost half of the Class II patients had some evidence of renal disease, including elevated serum creatinine, as well as important non-glomerular lesions. Without biopsy they might have been thought to have proliferative lesions and been treated more aggressively. Two patients with proliferative glomerulonephritis had no clinical evidence of renal disease. Thus, at the time of biopsy results renal histological examination did not uniformly correlate with clinical renal disease.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2616734

Source DB:  PubMed          Journal:  Q J Med        ISSN: 0033-5622


  8 in total

Review 1.  Kidney disease in systemic lupus erythematosus.

Authors:  J E Balow
Journal:  Rheumatol Int       Date:  1991       Impact factor: 2.631

2.  Outcomes of children with proliferative lupus nephritis: the role of protocol renal biopsy.

Authors:  David Askenazi; Barry Myones; Ankur Kamdar; Robert Warren; Maria Perez; Marietta De Guzman; Anna Minta; M John Hicks; Arundhati Kale
Journal:  Pediatr Nephrol       Date:  2007-03-03       Impact factor: 3.714

3.  Low-Level Proteinuria in Systemic Lupus Erythematosus.

Authors:  Alice Chedid; Giovanni M Rossi; Francesco Peyronel; Steven Menez; Mohamed G Atta; Serena M Bagnasco; Lois J Arend; Avi Z Rosenberg; Derek M Fine
Journal:  Kidney Int Rep       Date:  2020-09-18

4.  Activated C3 (C3b) in the nephritic glomerulus.

Authors:  C Pan; C F Strife; A J McAdams; C D West
Journal:  Pediatr Nephrol       Date:  1993-08       Impact factor: 3.714

5.  Pattern of systemic lupus erythematosus in Egyptian patients: the impact of disease activity on the quality of life.

Authors:  Hamdy Sliem; Gamal Tawfik; Khalil A Khalil; Nagwa Ibrahim
Journal:  Pan Afr Med J       Date:  2010-08-23

6.  Clinical and laboratory predictors of distinct histopathogical features of lupus nephritis.

Authors:  Clio P Mavragani; George E Fragoulis; George Somarakis; Alexandros Drosos; Athanasios G Tzioufas; Haralampos M Moutsopoulos
Journal:  Medicine (Baltimore)       Date:  2015-05       Impact factor: 1.889

7.  Comparison Study on the Effect of Treatment Decision Based on Renal Biopsy and Clinical Symptoms in the Outcome of Patients with Recurrent Lupus Nephritis.

Authors:  Hadi Karimzadeh; Shokrollah Hasani; Zahra Sayedbonakdar; Ali Mehrabi Koushki
Journal:  Adv Biomed Res       Date:  2017-11-30

8.  The potential diagnostic utility of coexpression of Ki-67 and P53 in the renal biopsy in pediatric lupus nephritis.

Authors:  Mahtab H Rahbar; Maryam R Rahbar; Nyousha Mardanpour; Sourena Mardanpour
Journal:  Int J Nephrol Renovasc Dis       Date:  2018-12-12
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.